D75.0 Familial erythrocytosis

Name of the Condition

• Familial erythrocytosis

Summary

Familial erythrocytosis is a hereditary condition characterized by an increased number of red blood cells (erythrocytosis) in the blood. This elevation can lead to higher blood viscosity, potentially increasing the risk of thrombotic events. The condition is inherited and typically presents with elevated hemoglobin or hematocrit levels without an identifiable secondary cause.

Causes

Familial erythrocytosis is caused by genetic mutations that affect the regulation of red blood cell production. These mutations may involve genes responsible for oxygen sensing or erythropoietin signaling, leading to overproduction of red blood cells. The condition is passed down through families in an autosomal dominant or recessive pattern, depending on the specific genetic variant.

Risk Factors

• Family history of erythrocytosis or related blood disorders.
• Inherited genetic mutations associated with red blood cell overproduction.
• Certain ethnic or familial backgrounds where the condition is more prevalent.

Symptoms

• Headaches or dizziness due to increased blood viscosity.
• Blurred vision or visual disturbances.
• Fatigue or weakness, though some individuals may be asymptomatic.
• In severe cases, symptoms of thrombosis, such as chest pain or shortness of breath.

Diagnosis

Diagnosis involves confirming elevated red blood cell counts (hemoglobin or hematocrit) and ruling out secondary causes of erythrocytosis, such as chronic hypoxia or tumors. Genetic testing may be performed to identify specific mutations. Additional tests, including arterial blood gas analysis or imaging, may be used to exclude underlying conditions.

Treatment Options

Treatment focuses on managing symptoms and reducing the risk of complications. Therapeutic phlebotomy (removing blood) may be used to lower red blood cell counts. Low-dose aspirin is sometimes recommended to reduce thrombotic risk. Monitoring and managing blood viscosity are key to preventing adverse events.

Prognosis and Follow-Up

The prognosis is generally good with appropriate management, though untreated cases may increase the risk of thrombosis. Regular follow-up with blood tests to monitor red blood cell levels and assess for complications is essential. Lifestyle modifications and adherence to treatment plans can help maintain quality of life.

Complications

• Increased risk of blood clots (thrombosis) in veins or arteries.
• Potential for organ damage due to reduced blood flow from high viscosity.
• Rarely, progression to more severe hematologic disorders.

Lifestyle & Prevention

• Stay hydrated to help reduce blood viscosity.
• Avoid smoking, as it can exacerbate thrombotic risk.
• Follow medical advice regarding phlebotomy or medication use.
• Inform healthcare providers of family history for early screening.

When to Seek Professional Help

Seek medical attention if experiencing sudden symptoms like chest pain, shortness of breath, or signs of stroke (e.g., weakness, speech changes). Regular check-ups are recommended for those with a family history of the condition to monitor blood counts and manage risks.

Tips for Medical Coders

When coding for familial erythrocytosis, ensure documentation supports the hereditary nature and excludes secondary causes. Verify that the diagnosis aligns with the clinical presentation and genetic testing results, if available. Accurate coding requires clear documentation of the condition’s familial basis and any associated complications.